About Xilis

Cancer is the second leading cause of death in the U.S and metastatic disease remains predominantly incurable. New cancer cases and healthcare costs continue to increase year-over-year. Precision medicine helps select the most effective treatments for patients.

Xilis is developing next generation organoid technologies to guide precision therapy for cancer patients and accelerate drug discovery.